Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 1.65 | 1.89 | 3.69 |
| 6M | 18.51 | 4.24 | 25.25 |
| 1Y | 12.45 | 7.47 | 20.19 |
| 3Y | 19.60 | 18.82 | 93.81 |
DSP Healthcare Fund Growth managed by DSP Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹3,514 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 1.97. Under the expert guidance of Chirag Dagli ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Chirag Dagli holds Chartered Accountant (ICAI India) and also holds a Bachelor of Commerce Degree. Chirag has also worked with HDFC AMC Limited, Aviva life Insurance, ICICI Securities, Infinity.com Financial Services Limited, Global Markets - Deutsche Equities India Private Limited, Citigroup Global Markets India Private Limited and ICICI Securities.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| Nippon India Pharma Fund Growth | 4 | 9,044 CR | 1.86 |
| Tata India Pharma & HealthCare Fund Growth | 2 | 1,455 CR | 2.25 |
| DSP Healthcare Fund Growth | 3 | 3,514 CR | 1.97 |
| SBI Healthcare Opportunities Fund Growth | 3 | 4,997 CR | 2.01 |
| UTI Healthcare Fund Growth | 3 | 1,307 CR | 2.26 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundNippon India Pharma Fund Growth | 10.8006 | 66.1627 |
| This FundTata India Pharma & HealthCare Fund Growth | 11.0332 | 69.8878 |
| This FundDSP Healthcare Fund Growth | 12.4451 | 71.0706 |
| This FundSBI Healthcare Opportunities Fund Growth | 18.9823 | 87.628 |
| This FundUTI Healthcare Fund Growth | 15.6253 | 88.1993 |